Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature.
about
Quantitative analysis of BTF3, HINT1, NDRG1 and ODC1 protein over-expression in human prostate cancer tissueCancer biomarker discovery: the entropic hallmark.Laser-capture microdissection in prostate cancer research: establishment and validation of a powerful tool for the assessment of tumour-stroma interactions.Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma.PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study.NKX3.1 as a marker of prostatic origin in metastatic tumors.Cutaneous metastasis of prostate carcinoma treated with radiotherapy: a case presentation.Quantitative Time-Resolved Fluorescence Imaging of Androgen Receptor and Prostate-Specific Antigen in Prostate Tissue Sections.TrAp: a tree approach for fingerprinting subclonal tumor composition.Differential Immunohistochemical Profiles for Distinguishing Prostate Carcinoma and Urothelial Carcinoma.A retrospective study of prostate cancer cases mimicking urothelial cell carcinoma of the bladder.Review of small cell carcinomas of the prostate.Cyr61 is a potential prognostic marker for prostate cancer.Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.Prostate carcinoma metastatic to the skin as an extrammamary Paget's disease.Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma.Sarcoidosis vs. Sarcoid-like reactions: The Two Sides of the same Coin?Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma.Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients.Histopathological features of intra-ductal carcinoma of prostatic and high grade prostatic intraepithelialneoplasia and correlation with PTEN and P63.Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.Diagnostic utility of α-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer.Diagnostic utility of a p63/alpha-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy.Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions.Prostate adenocarcinoma with negative immunohistochemical stain of prostate-specific antigen presenting with cervical mass: A case report.A systematic analysis of commonly used antibodies in cancer diagnostics.Performance of different prostate specific antibodies in the cytological diagnosis of metastatic prostate adenocarcinoma.Impact of the Pathologist on Prostate Biopsy Diagnosis and Immunohistochemical Stain Usage Within a Single Institution.Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases.AMACR is highly expressed in gastric adenomas and intestinal-type carcinomas.Immunohistochemical profile of ductal adenocarcinoma of the prostate.
P2860
Q21132372-84609BC1-81AC-42CE-9789-DD6E434CD70DQ30496149-6D5AC85E-C2BE-4CA7-AEC2-3BCE5B3DE3CDQ33314416-0A639D22-C034-44A2-9623-210F46906F6CQ33658239-8F8F26F5-B4A2-417D-A36E-C957B3795584Q33897290-C65B80D5-7CEB-4F49-BAD4-A5F980E3A7F6Q34123290-374759F5-EBFB-4B17-B87E-5BC889A1757EQ35221487-4BB59989-0BD7-4865-8FD6-96095A87550EQ36852430-78663030-B903-4385-B4FD-E7430191596BQ37197845-73C46A7D-5D26-43BB-81F8-94774673E3A3Q37297806-470FB5A0-CE9A-4144-B055-6F239BEBBA92Q37365428-401C581E-1717-4FBA-A243-59D7FF34B0ABQ37960020-5212641C-782C-425B-8297-B8A2872BFD84Q37985500-7A7DB711-233E-4927-8B27-31FE8D470C59Q37996298-4E6F3EFA-B815-42E1-BC02-8FA9ED9B0B98Q38035520-BEBC8DE6-B47D-49C6-85C7-22598E94AA21Q38115193-B4D3A4F9-680A-438E-80A2-214CF9B432BAQ38199005-DF7AEA6C-0426-49F4-9121-10AB1F5821B2Q38269382-33438054-0784-464D-AF13-3372167FE105Q38676256-98C6BEFE-E58C-410E-9166-83CB2756BC14Q40236945-599A6A2D-E77B-4600-8CA8-1AD841BCBB16Q41307496-1F348B1D-622F-4C0A-9E76-40A6E596E29EQ42155258-C7FCADE7-6A7F-4E05-9DA3-850E47B0F070Q42494027-40BCAB55-0F28-4B0A-B849-A07E9497286FQ42513914-CD5C9C47-3C8E-4D07-8153-6E7355F47562Q42776324-22123D77-D2ED-4D40-A73C-CDDDD6A597F4Q46602608-0441D699-0429-4937-8564-96324BBC4EB6Q48098802-2E8DBB8F-5F85-4AB6-97A3-05F8E0B70243Q49813501-BDC88DAA-D5A7-4222-9FC1-437635FB7D67Q50901820-A7A1337A-030E-473C-AE78-41C09AE3A292Q53569065-98149C6A-F04E-40E2-8D91-AE27AC3F0A80Q54335249-998F1EF6-1E41-44F2-B83E-796C28B08174
P2860
Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Diagnostic utility of immunohi ...... review of current literature.
@ast
Diagnostic utility of immunohi ...... review of current literature.
@en
type
label
Diagnostic utility of immunohi ...... review of current literature.
@ast
Diagnostic utility of immunohi ...... review of current literature.
@en
prefLabel
Diagnostic utility of immunohi ...... review of current literature.
@ast
Diagnostic utility of immunohi ...... review of current literature.
@en
P2860
P1433
P1476
Diagnostic utility of immunohi ...... review of current literature.
@en
P2093
P2860
P356
10.1111/J.1365-2559.2005.02188.X
P577
2005-07-01T00:00:00Z